Cargando…

Quinacrine, an Old Drug with Potentially usefull in the Treatment for COVID-19

Detalles Bibliográficos
Autor principal:	PINEDA, BENJAMIN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. 2021
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180551/ https://www.ncbi.nlm.nih.gov/pubmed/34154830 http://dx.doi.org/10.1016/j.arcmed.2021.06.002

Ejemplares similares

The usefullness of basic physics research
por: Jacob, Maurice René Michel
Publicado: (2003)

Palate Mucoperosteum: An Usefull Adjunct in Buccal Mucosa Reconstruction
por: Manjunath, KN, et al.
Publicado: (2017)

Treatment of Oriental Sore with Quinacrine
por: Sachdeva, Y. V.
Publicado: (1943)

Continuous Quinacrine Treatment Results in the Formation of Drug-Resistant Prions
por: Ghaemmaghami, Sina, et al.
Publicado: (2009)

Monogenetic autoinflammatory syndromes and nephrology - therapy is usefull even in advanced kidney failure
por: Hohenstein-Scheibenecker, K, et al.
Publicado: (2015)

RE: Some Usefull Techniques to Succeed in Endovenous Laser Ablation with Antegrade Access
por: Aribal, Serkan, et al.
Publicado: (2016)

Quinacrine Treatment of Nitroimidazole-Refractory Giardiasis
por: Ydsten, Karin A, et al.
Publicado: (2021)

Pharmacokinetics of quinacrine in the treatment of prion disease
por: Yung, Lotus, et al.
Publicado: (2004)

Toxic Symptoms Associated with Quinacrine Treatment
por: Nandi, D. K.
Publicado: (1947)

Candidate drug replacements for quinacrine in cutaneous lupus erythematosus
por: Yan, Daisy, et al.
Publicado: (2020)

Parenteral Quinacrine in Malarial Fevers
por: Basumullick, K. L., et al.
Publicado: (1947)

Usefullness of palatal rugae patterns in establishing identity: Preliminary results from Bengaluru city, India
por: Indira, AP, et al.
Publicado: (2012)

Quinacrine in the Eradication of Giardia Lamblia Infection
por: Pant, K. C., et al.
Publicado: (1942)

Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia
por: Eriksson, A, et al.
Publicado: (2015)

Quinacrine, an Antimalarial Drug with Strong Activity Inhibiting SARS-CoV-2 Viral Replication In Vitro
por: Salas Rojas, Mónica, et al.
Publicado: (2021)

Repurposing the anti-malarial drug, quinacrine: new anti-colitis properties
por: Chumanevich, Alexander A., et al.
Publicado: (2016)

Pramipexole: new use for an old drug – the potential use of pramipexole in the treatment of restless legs syndrome
por: Benbir, Gulcin, et al.
Publicado: (2006)

Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease
por: Lane, Thomas R., et al.
Publicado: (2020)

S1 Subunit and Host Proteases as Potential Therapeutic Avenues for the Treatment of COVID-19
por: Arafah, Azher, et al.
Publicado: (2020)

Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic
por: Dunlop, Adrian, et al.
Publicado: (2020)

Two Cases Showing Cerebral Symptoms after Treatment with Quinacrine for Malaria
por: Berry, J. N.
Publicado: (1945)

Repositioning Quinacrine Toward Treatment of Ovarian Cancer by Rational Combination With TRAIL
por: Liang, Rui, et al.
Publicado: (2020)

Repurposing Quinacrine for Treatment of Malignant Mesothelioma: In-Vitro Therapeutic and Mechanistic Evaluation
por: Kulkarni, Nishant S., et al.
Publicado: (2020)

Transporter Inhibition Profile for the Antivirals Tilorone, Quinacrine and Pyronaridine
por: Vignaux, Patricia A., et al.
Publicado: (2023)

Usefullness of Heparin Calibrated Anti-Xa Activity to Assess Anticoagulant Activity of Apixaban and Rivaroxaban in Emergency Patients Scheduled for Acute Interventions
por: Riahi, Nada, et al.
Publicado: (2023)

Pharmacokinetic considerations to optimize clinical outcomes for COVID-19 drugs
por: Nwabufo, Chukwunonso K., et al.
Publicado: (2022)

Quinacrine Induces Nucleolar Stress in Treatment-Refractory Ovarian Cancer Cell Lines
por: Oien, Derek B., et al.
Publicado: (2021)

Role of monoclonal antibody drugs in the treatment of COVID-19
por: Ucciferri, Claudio, et al.
Publicado: (2020)

Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity
por: Hache, Guillaume, et al.
Publicado: (2021)

Amantadine Treatment for People with COVID-19
por: Araújo, Ramiro, et al.
Publicado: (2020)

Multimodal Investigation into the Interaction of Quinacrine with Microcavity-Supported Lipid Bilayers
por: Sarangi, Nirod Kumar, et al.
Publicado: (2022)

Insights from nanotechnology in COVID-19 treatment
por: Tang, Zhongmin, et al.
Publicado: (2021)

Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role
por: Samuel, Samson Mathews, et al.
Publicado: (2021)

The COVID-19 Pandemic—A Potential Role for Antivirals in Mitigating Pandemics
por: Neumann, Gabriele, et al.
Publicado: (2023)

FDA approved drugs as potential Ebola treatments
por: Ekins, Sean, et al.
Publicado: (2015)

Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
por: Kyrou, Ioannis, et al.
Publicado: (2020)

Sofosbuvir as Repurposed Antiviral Drug Against COVID-19: Why Were We Convinced to Evaluate the Drug in a Registered/Approved Clinical Trial?
por: Sayad, Babak, et al.
Publicado: (2020)

Autophagic flux inhibition and lysosomogenesis ensuing cellular capture and retention of the cationic drug quinacrine in murine models
por: Parks, Alexandre, et al.
Publicado: (2015)

Quinacrine-CASIN combination overcomes chemoresistance in human acute lymphoid leukemia
por: Wu, Limei, et al.
Publicado: (2021)

Endometrial abnormalities on transvaginal ultrasonography and histopathology in women after quinacrine sterilization
por: Afzal, Saira, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_93rq657jhd6l2br7jetoofh91o